Divis Laboratories: Consolidated Balance Sheet of - in Rs. Cr.

Consolidated Balance Sheet of Divis
------------------- in Rs. Cr. -------------------
Laboratories
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
26.55
26.52
26.43
12.95
12.91
Equity Share Capital
26.55
26.52
26.43
12.95
12.91
Share Application Money
0.00
0.00
0.00
0.00
0.00
Preference Share Capital
0.00
0.00
0.00
0.00
0.00
Init. Contribution Settler
0.00
0.00
0.00
0.00
0.00
Preference Share Application Money
0.00
0.00
0.00
0.00
0.00
Sources Of Funds
Employee Stock Opiton
0.00
0.00
0.00
0.00
0.00
Reserves
2,104.98
1,770.96
1,491.38
1,228.43
848.49
Revaluation Reserves
Networth
0.00
2,131.53
0.00
1,797.48
0.00
1,517.81
0.00
1,241.38
0.00
861.40
50.20
20.16
29.85
49.52
82.96
Secured Loans
Unsecured Loans
2.56
2.88
3.00
3.12
3.12
52.76
23.04
32.85
52.64
86.08
Minority Interest
0.00
0.00
0.00
0.00
0.00
Policy Holders Funds
0.00
0.00
0.00
0.00
0.00
Total Debt
Group Share in Joint Venture

Total Liabilities
0.00
0.00
0.00
0.00
0.00
2,184.29
1,820.52
1,550.66
1,294.02
947.48
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Application Of Funds
Gross Block
1,092.05
885.70
832.93
782.77
642.17
Less: Accum. Depreciation

Net Block
353.64
738.41
295.77
589.93
243.10
589.83
192.90
589.87
145.11
497.06
Capital Work in Progress
181.99
129.33
23.75
19.50
63.08
Investments
477.04
525.64
441.28
171.80
55.57
Inventories
678.96
571.71
498.50
421.28
281.41
Sundry Debtors
495.58
367.41
223.20
266.01
209.45
30.94
14.79
13.69
9.07
7.65
Total Current Assets
1,205.48
953.91
735.39
696.36
498.51
Loans and Advances
153.73
82.03
72.97
71.50
62.15
0.00
2.88
2.77
5.71
6.55
1,359.21
1,038.82
811.13
773.57
567.21
0.00
0.00
0.00
0.00
0.00
Current Liabilities
362.51
301.39
218.91
211.77
198.90
Provisions
209.86
161.80
96.45
48.94
36.56
Total CL & Provisions
572.37
463.19
315.36
260.71
235.46
Net Current Assets
786.84
575.63
495.77
512.86
331.75
Cash and Bank Balance
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit
Minority Interest
0.00
0.00
0.00
0.00
0.00
Group Share in Joint Venture
0.00
0.00
0.00
0.00
0.00
0.00
2,184.28
0.00
1,820.53
0.00
1,550.63
0.00
1,294.03
0.00
947.46
Miscellaneous Expenses
Total Assets
Contingent Liabilities
101.74
72.70
97.21
86.94
114.67
Book Value (Rs)
160.59
135.56
114.86
191.70
133.43
Balance Sheet of Cipla
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
160.58
160.58
160.58
155.46
155.46
160.58
160.58
160.58
155.46
155.46
0.00
0.00
0.00
0.00
0.00

Reserves
0.00
7,380.73
0.00
6,443.40
0.00
5,744.54
0.00
4,186.32
0.00
3,591.39
Sources Of Funds
Networth
8.97
8.97
8.97
8.97
8.97
7,550.28
6,612.95
5,914.09
4,350.75
3,755.82
Secured Loans
10.00
2.95
0.41
2.79
16.98
Unsecured Loans
Total Debt
2.20
12.20
438.44
441.39
4.66
5.07
937.45
940.24
563.55
580.53
7,562.48
7,054.34
5,919.16
5,290.99
4,336.35
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Gross Block
4,298.18
3,929.00
2,895.44
2,693.29
2,201.79

Net Block
1,295.52
3,002.66
1,060.98
2,868.02
884.27
2,011.17
700.80
1,992.49
540.43
1,661.36

Investments
420.73
1,035.15
253.07
570.28
684.24
265.10
366.32
81.32
233.12
94.75
Inventories
Sundry Debtors
1,824.50
1,519.31
1,883.16
1,497.04
1,512.58
1,552.71
1,398.32
1,837.15
1,120.49
1,393.91
Total Liabilities
53.82
83.56
60.32
52.84
79.12
3,397.63
3,463.76
3,125.61
3,288.31
2,593.52
Loans and Advances
1,136.14
2,558.23
2,357.29
1,131.10
1,150.30
1.48
0.57
0.52
0.16
0.16
4,535.25
6,022.56
5,483.42
4,419.57
3,743.98
Fixed Deposits
Deffered Credit
Current Liabilities
Provisions
0.00
0.00
0.00
0.00
0.00
1,190.78
1,150.72
1,177.11
1,177.00
980.05
240.53
1,508.87
1,347.66
391.71
416.81
1,431.31
2,659.59
2,524.77
1,568.71
1,396.86
Net Current Assets
3,103.94
3,362.97
2,958.65
2,850.86
2,347.12
Total Assets
0.00
7,562.48
0.00
7,054.34
0.00
5,919.16
0.00
5,290.99
0.00
4,336.35
608.80
478.26
423.87
730.75
1,664.58
93.92
82.25
73.55
55.86
48.20
Book Value (Rs)
Balance Sheet of Dr
Reddys
------------------- in Rs. Cr. -------------------
Laboratories
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
84.80
84.60
84.40
84.20
84.09

84.80
0.00
84.60
0.00
84.40
0.00
84.20
0.00
84.09
0.00

Reserves
0.00
6,633.00
0.00
5,935.60
0.00
5,830.20
0.00
5,174.90
0.00
4,727.72
Networth
0.00
6,717.80
0.00
6,020.20
0.00
5,914.60
0.00
5,259.10
0.00
4,811.81
Sources Of Funds
Secured Loans
0.50
0.70
0.80
2.60
3.40
1,532.90
1,533.40
8,251.20
1,444.10
1,444.80
7,465.00
562.40
563.20
6,477.80
637.70
640.30
5,899.40
458.91
462.31
5,274.12
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Gross Block
3,507.80
3,025.00
2,425.70
2,157.30
1,750.21

Net Block
1,611.00
1,896.80
1,334.00
1,691.00
1,110.10
1,315.60
946.50
1,210.80
762.80
987.41

Investments
637.60
2,477.70
570.40
2,462.00
745.40
2,652.70
411.20
1,865.10
245.71
2,080.71
Inventories
1,326.70
1,063.20
897.40
735.10
640.93
Sundry Debtors
1,943.50
93.10
1,770.50
66.20
1,060.50
47.90
1,419.70
84.30
897.71
67.19
3,363.30
2,899.90
2,005.80
2,239.10
1,605.83
Unsecured Loans
Total Debt
Total Liabilities
Loans and Advances

Fixed Deposits
1,291.40
755.90
1,663.80
0.00
1,321.40
320.10
1,331.20
300.10
1,272.02
470.15
5,410.60
4,563.70
3,647.30
3,870.40
3,348.00
0.00
0.00
0.00
0.00
0.00
1,534.30
1,565.20
1,543.80
1,163.30
786.36
637.20
256.90
339.40
294.80
601.38

Net Current Assets
2,171.50
3,239.10
1,822.10
2,741.60
1,883.20
1,764.10
1,458.10
2,412.30
1,387.74
1,960.26
Total Assets
0.00
8,251.20
0.00
7,465.00
0.00
6,477.80
0.00
5,899.40
0.00
5,274.09
2,018.90
1,526.00
2,016.10
1,934.80
1,892.55
396.19
355.69
350.30
312.17
286.1
Deffered Credit
Current Liabilities
Provisions
Book Value (Rs)
Balance Sheet of Biocon
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
100.00
100.00
100.00
100.00
50.00
100.00
100.00
100.00
100.00
50.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1,995.50
1,845.86
1,465.34
1,273.93
1,277.25
0.90
0.95
0.95
0.95
0.95
2,096.40
1,946.81
1,566.29
1,374.88
1,328.20
Sources Of Funds

Reserves
Networth
Secured Loans
5.60
74.06
89.68
162.61
143.57
141.70
147.30
94.57
168.63
102.12
191.80
1.33
163.94
0.32
143.89
2,243.70
Mar '12
2,115.44
Mar '11
1,758.09
Mar '10
1,538.82
Mar '09
1,472.09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
1,197.10
1,105.91
1,020.21
987.50
880.11

Net Block
512.10
685.00
426.22
679.69
341.81
678.40
273.33
714.17
200.65
679.46

Investments
113.80
657.00
103.29
485.82
58.33
418.64
37.69
346.69
64.63
477.26
Inventories
340.40
274.74
244.80
194.52
167.74
Unsecured Loans
Total Debt
Total Liabilities
Gross Block
Sundry Debtors
445.00
37.80
418.10
185.20
383.64
77.11
310.17
5.29
225.66
4.91
823.20
878.04
705.55
509.98
398.31
Loans and Advances
543.10
412.41
407.33
270.33
123.55
Fixed Deposits
2.20
25.03
0.01
0.76
3.21
1,368.50
1,315.48
1,112.89
781.07
525.07
Deffered Credit
Current Liabilities
0.00
431.80
0.00
358.64
0.00
426.92
0.00
264.79
0.00
206.18
Provisions
148.80
110.19
83.25
76.00
68.17

Net Current Assets
580.60
787.90
468.83
846.65
510.17
602.72
340.79
440.28
274.35
250.72
0.00
2,243.70
0.00
2,115.45
0.00
1,758.09
0.00
1,538.83
0.00
1,472.07
204.40
154.90
261.74
173.88
146.17
Book Value (Rs)
104.78
97.29
78.27
68.70
132.72
Total Assets
Balance Sheet of
Aurobindo Pharma
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Total Share Capital
29.11
29.11
27.86
26.88
26.88
29.11
29.11
27.86
26.88
26.88

Reserves
0.00
0.00
2,464.06
0.00
0.00
2,540.50
0.00
0.00
1,886.50
0.00
0.00
1,293.95
0.00
0.00
1,193.72
Networth
0.00
2,493.17
0.00
2,569.61
0.00
1,914.36
0.00
1,320.83
0.00
1,220.60
Secured Loans
Unsecured Loans
Total Debt
2,346.33
95.62
2,441.95
1,038.01
1,279.71
2,317.72
702.25
1,242.53
1,944.78
813.02
1,301.66
2,114.68
581.87
1,173.78
1,755.65
Total Liabilities
4,935.12
4,887.33
3,859.14
3,435.51
2,976.25
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Gross Block
2,359.40
1,955.17
1,526.88
1,258.70
1,132.01

Net Block
732.66
1,626.74
605.28
1,349.89
481.54
1,045.34
385.83
872.87
304.93
827.08
563.56
582.92
499.47
285.96
124.69
Sources Of Funds
Investments
629.00
493.09
379.24
277.74
290.04
Inventories
Sundry Debtors
1,219.26
1,426.28
1,261.02
1,480.71
944.82
1,151.35
735.52
1,105.67
651.23
798.97

14.01
2,659.55
4.21
2,745.94
4.02
2,100.19
79.03
1,920.22
3.42
1,453.62
677.41
0.12
568.61
118.12
593.67
0.54
696.60
7.91
584.78
235.90

Deffered Credit
3,337.08
0.00
3,432.67
0.00
2,694.40
0.00
2,624.73
0.00
2,274.30
0.00
Current Liabilities
Provisions
1,159.59
61.67
913.82
57.42
719.94
39.37
595.02
30.77
506.06
33.80

Net Current Assets
1,221.26
2,115.82
971.24
2,461.43
759.31
1,935.09
625.79
1,998.94
539.86
1,734.44
Total Assets
0.00
4,935.12
0.00
4,887.33
0.00
3,859.14
0.00
3,435.51
0.00
2,976.25
74.59
219.10
139.04
90.03
180.41
Book Value (Rs)
85.64
88.27
343.51
245.67
227.02
Loans and Advances

Fixed Deposits
P&L A/c
Profit & Loss account of Divis Laboratories
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
1,862.74
1,323.69
937.20
1,201.07
1,043.29
Income
Sales Turnover
Excise Duty
17.92
13.99
5.57
7.71
7.90
Net Sales
1,844.82
1,309.70
931.63
1,193.36
1,035.39
Other Income
Stock Adjustments
Total Income
Expenditure
64.34
10.89
1,920.05
34.12
-34.59
1,309.23
23.94
99.07
1,054.64
-13.85
98.54
1,278.05
-6.04
32.16
1,061.51
Raw Materials
Power & Fuel Cost
798.77
86.13
508.58
62.65
410.06
45.13
557.81
49.93
458.40
38.31
Employee Cost
Other Manufacturing Expenses
145.16
22.39
112.06
15.66
93.22
10.31
89.34
10.35
65.92
10.47
Selling and Admin Expenses

82.17
23.06
56.26
19.25
37.51
13.15
43.59
13.64
47.25
10.61
Preoperative Exp Capitalised

Total Expenses
0.00
1,157.68
Mar '12
0.00
774.46
Mar '11
0.00
609.38
Mar '10
0.00
764.66
Mar '09
0.00
630.96
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Operating Profit
698.03
500.65
421.32
527.24
436.59
PBDIT
762.37
534.77
445.26
513.39
430.55
4.34
2.19
2.76
7.23
10.18
PBDT
Depreciation
758.03
62.03
532.58
53.35
442.50
51.45
506.16
47.82
420.37
35.65
Other Written Off

Profit Before Tax
0.00
696.00
0.00
479.23
0.00
391.05
0.00
458.34
0.00
384.72
Extra-ordinary items
PBT (Post Extra-ord Items)
-1.11
694.89
-0.01
479.22
-0.10
390.95
0.16
458.50
-1.59
383.13
Tax
Reported Net Profit
148.05
545.97
43.48
435.57
44.14
344.20
34.09
424.46
29.54
353.56
Total Value Addition

Preference Dividend
Equity Dividend
358.90
0.00
172.55
265.88
0.00
132.60
199.33
0.00
79.29
206.86
0.00
38.91
172.56
0.00
25.82
27.99
21.51
13.17
6.62
4.39
1,327.34
1,325.95
1,321.44
647.58
645.57
Interest
Corporate Dividend Tax

Per share data (annualised)
Shares in issue (lakhs)
Earning Per Share (Rs)

Equity Dividend (%)
Book Value (Rs)
41.13
32.85
26.05
65.54
54.77
650.00
163.85
500.00
137.87
300.00
116.70
300.00
194.85
200.00
135.38
Profit & Loss account of Cipla
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
7,074.73
97.23
6,977.50
6,368.06
48.71
6,319.35
5,657.85
52.16
5,605.69
5,295.33
61.04
5,234.29
4,293.95
90.66
4,203.29
96.50
109.80
125.71
-139.51
134.92
-11.24
7,062.76
125.74
6,554.89
184.09
5,915.49
113.55
5,208.33
41.37
4,379.58
2,903.95
3,085.90
2,687.54
2,513.11
2,162.48
188.18
164.42
92.15
91.71
96.90
644.79
259.56
1,217.79
464.20
270.08
999.68
318.87
259.67
867.98
271.33
262.65
887.28
255.45
233.90
547.10
154.27
179.49
182.64
76.92
96.66
0.00
0.00
0.00
0.00
0.00
5,368.54
Mar '12
5,163.77
Mar '11
4,408.85
Mar '10
4,103.00
Mar '09
3,392.49
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Operating Profit
1,597.72
1,281.32
1,380.93
1,244.84
852.17
PBDIT
Interest
PBDT
1,694.22
12.13
1,682.09
1,391.12
10.87
1,380.25
1,506.64
28.30
1,478.34
1,105.33
52.23
1,053.10
987.09
18.05
969.04
Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Employee Cost
Total Expenses
Depreciation
261.08
228.86
165.25
151.79
130.68
Other Written Off
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,421.01
1,151.39
1,313.09
901.31
838.36
0.45
0.00
11.90
0.00
0.00

Tax
Reported Net Profit
1,421.46
297.50
1,123.96
1,151.39
191.00
960.39
1,324.99
243.50
1,081.49
901.31
124.50
776.81
838.36
136.93
701.43

Preference Dividend
2,464.59
0.00
2,077.87
0.00
1,721.31
0.00
1,589.89
0.00
1,230.01
0.00
Equity Dividend
Equity Dividend (%)
Book Value (Rs)
160.58
26.05
224.81
36.72
160.58
26.67
155.46
26.42
155.46
26.42
8,029.21
14.00
8,029.21
11.96
8,029.21
13.47
7,772.91
9.99
7,772.91
9.02
100.00
140.00
100.00
100.00
100.00
93.92
82.25
73.55
55.86
48.20
Profit & Loss account of Dr Reddys

Laboratories
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Sales Turnover
6,780.20
5,285.80
4,469.60
4,080.40
3,428.40
Excise Duty
Net Sales
93.90
6,686.30
97.30
5,188.50
74.00
4,395.60
80.90
3,999.50
84.51
3,343.89
-191.90
117.00
254.00
212.20
197.29
104.80
6,599.20
79.00
5,384.50
117.30
4,766.90
64.10
4,275.80
93.87
3,635.05
Income
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
2,122.90
1,749.50
1,599.40
1,534.00
1,347.33
Power & Fuel Cost
177.50
144.60
104.10
90.00
77.12
Employee Cost
831.20
702.70
516.40
412.50
366.28
163.10
129.50
117.30
105.90
130.35
1,554.40
1,256.70
1,036.60
1,117.90
896.54
80.30
65.00
50.60
45.30
37.44
0.00
0.00
0.00
0.00
0.00
4,929.40
Mar '12
4,048.00
Mar '11
3,424.40
Mar '10
3,305.60
Mar '09
2,855.06
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Operating Profit
1,861.70
1,219.50
1,088.50
758.00
582.70
PBDIT
1,669.80
1,336.50
1,342.50
970.20
779.99
69.20
9.90
16.00
27.40
14.69
PBDT
Depreciation
1,600.60
301.10
1,326.60
247.90
1,326.50
222.40
942.80
193.60
765.30
161.99
Other Written Off

Profit Before Tax
40.30
1,259.20
26.80
1,051.90
19.30
1,084.80
19.70
729.50
20.71
582.60
-0.30
-0.40
-0.10
-0.10
-0.06
1,258.90
1,051.50
1,084.70
729.40
582.54
346.80
158.50
238.70
168.60
108.88

Total Expenses
Interest
Tax
Reported Net Profit
912.40
893.40
846.10
560.90
475.22
2,806.50
2,298.50
1,825.00
1,771.60
1,507.73
Preference Dividend
0.00
0.00
0.00
0.00
0.00
233.10
190.40
190.00
105.30
63.06
37.80
115.20
31.60
17.80
10.72
1,695.60
53.81
1,692.53
52.78
1,688.45
50.11
1,684.69
33.29
1,681.73
28.26
Equity Dividend (%)
275.00
225.00
225.00
125.00
75.00
Book Value (Rs)
396.19
355.69
350.30
312.17
286.12
Equity Dividend
Profit & Loss account of Biocon
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Sales Turnover
Excise Duty
1,605.30
50.00
1,365.29
38.96
1,158.35
29.90
929.90
25.69
860.23
26.24
Net Sales
1,555.30
1,326.33
1,128.45
904.21
833.99
66.60
293.00
94.70
-15.59
409.77
41.40
1,663.30
27.84
1,647.17
38.95
1,262.10
26.77
915.39
11.96
1,255.72
818.90
694.62
608.77
442.85
410.66
Income
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
97.70
81.63
67.25
71.22
76.12
191.50
145.43
99.84
80.42
66.81
19.00
16.29
12.32
13.67
12.79
120.40
15.70
0.00
1,263.20
Mar '12
86.62
12.38
0.00
1,036.97
Mar '11
105.37
10.60
0.00
904.15
Mar '10
102.71
10.83
0.00
721.70
Mar '09
87.92
15.38
0.00
669.68
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Operating Profit
333.50
317.20
263.25
209.28
176.27
PBDIT
Interest
400.10
1.70
610.20
2.38
357.95
1.99
193.69
4.94
586.04
3.09
PBDT
398.40
607.82
355.96
188.75
582.95
94.00
90.70
79.73
74.28
69.00
Employee Cost
Total Expenses
Depreciation
Other Written Off
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
304.40
517.12
276.23
114.47
513.95
0.00
304.40
0.00
517.12
0.00
276.23
7.73
122.20
-68.39
445.56
Tax
Reported Net Profit
48.90
255.50
57.87
459.25
27.87
248.36
10.40
111.80
10.64
434.92

Preference Dividend
Equity Dividend
444.30
0.00
100.00
342.35
0.00
90.00
295.38
0.00
70.00
278.85
0.00
60.00
259.01
0.00
50.00
16.20
9.08
7.41
10.20
8.50
2,000.00
12.78
2,000.00
22.96
2,000.00
12.42
2,000.00
5.59
1,000.00
43.49
Equity Dividend (%)
100.00
90.00
70.00
60.00
100.00
Book Value (Rs)
104.78
97.29
78.27
68.70
132.72

Profit & Loss account of Aurobindo Pharma
------------------- in Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
4,378.73
94.10
4,284.63
4,229.99
99.54
4,130.45
3,319.60
67.54
3,252.06
2,885.25
90.35
2,794.90
2,351.12
116.49
2,234.63
-525.06
17.61
112.22
-193.56
155.32
-89.87
3,669.70
136.37
4,284.43
147.48
3,511.76
28.94
2,630.28
31.18
2,421.13
2,599.02
225.54
2,487.19
184.55
2,010.02
135.48
1,750.75
118.32
1,491.36
96.32
Employee Cost
364.10
75.61
303.60
79.03
232.62
59.14
177.18
46.08
148.70
43.04

234.56
74.07
207.53
37.22
186.29
18.71
195.12
19.52
120.96
47.90

Total Expenses
0.00
3,572.90
Mar '12
0.00
3,299.12
Mar '11
0.00
2,642.26
Mar '10
0.00
2,306.97
Mar '09
0.00
1,948.28
Mar '08
12 mths
12 mths
12 mths
12 mths
12 mths
Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Operating Profit
621.86
967.70
757.28
516.87
317.53
PBDIT
96.80
985.31
869.50
323.31
472.85
Interest
93.11
55.02
62.58
81.20
59.01
3.69
930.29
806.92
242.11
413.84
PBDT
Depreciation
Other Written Off
Profit Before Tax
142.94
125.04
95.46
82.41
74.60
0.00
-139.25
-16.52
0.00
805.25
-0.95
0.00
711.46
-1.61
0.00
159.70
4.29
0.00
339.24
5.60
-155.77
804.30
709.85
163.99
344.84
Tax
Reported Net Profit
-113.16
-42.61
210.50
593.80
184.09
525.76
35.45
128.54
54.06
290.78
973.88
811.93
632.24
556.22
456.92
Preference Dividend
Equity Dividend
Equity Dividend (%)
Book Value (Rs)
0.00
0.00
0.00
0.00
0.00
29.11
4.72
58.72
9.64
27.74
4.67
24.20
4.11
17.57
2.98
2,911.21
-1.46
2,911.21
20.40
557.29
94.34
537.65
23.91
537.65
54.08
100.00
200.00
100.00
90.00
65.00
85.64
88.27
343.51
245.67
227.02
Financial Ratios
Consolidated Key Financial Ratios of Divis

Laboratories
------------------- in Rs. Cr. -------------------
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
2.00
2.00
2.00
2.00
2.00
--
--
--
--
--
Investment Valuation Ratios

Face Value
Dividend Per Share
Operating Profit Per Share (Rs)
52.01
37.40
31.20
80.89
66.59
140.43
--
98.90
133.45
71.43
112.51
182.70
186.28
160.33
128.33
Bonus in Equity Capital

Profitability Ratios
49.42
49.47
49.64
1.15
1.16
Operating Profit Margin(%)
37.03
37.82
43.67
44.27
41.53
Profit Before Interest And Tax Margin(%)

Gross Profit Margin(%)
32.72
33.70
32.96
33.74
37.28
38.21
39.57
40.22
37.66
38.08
Cash Profit Margin(%)

Adjusted Cash Margin(%)
Net Profit Margin(%)
31.00
31.00
27.77
35.88
35.88
31.97
40.10
40.10
35.17
41.93
41.93
34.64
38.50
36.65
33.21
Adjusted Net Profit Margin(%)

Return On Capital Employed(%)
27.77
31.33
31.97
26.01
35.17
24.66
34.64
38.03
33.21
42.03
Return On Net Worth(%)

Adjusted Return on Net Worth(%)
25.01
25.01
23.88
23.83
22.42
22.04
33.56
36.49
40.35
39.52
Return on Assets Excluding Revaluations
160.59
135.56
114.86
191.70
133.43
Return on Assets Including Revaluations

Return on Long Term Funds(%)
Liquidity And Solvency Ratios
160.59
31.33
135.56
26.21
114.86
24.75
191.70
38.09
133.43
42.88
Current Ratio
2.37
2.41
2.98
2.92
2.08
Quick Ratio
Debt Equity Ratio
1.19
0.02
1.13
0.01
1.17
0.02
1.33
0.04
1.20
0.10
Long Term Debt Equity Ratio

Debt Coverage Ratios
0.02
0.01
0.02
0.04
0.08
182.83
714.45
321.35
122.73
48.54
0.02
0.01
0.02
0.04
0.10
Financial Charges Coverage Ratio
199.42
239.20
156.81
75.02
43.31
Financial Charges Coverage Ratio Post Tax

Management Efficiency Ratios
160.05
220.05
142.67
65.60
39.34
Inventory Turnover Ratio
2.77
2.54
1.96
2.96
3.80
Debtors Turnover Ratio

Investments Turnover Ratio
4.32
2.77
4.44
2.54
3.86
1.96
4.98
2.96
5.58
3.80
Fixed Assets Turnover Ratio
1.71
1.48
1.13
1.51
1.61
Total Assets Turnover Ratio
0.85
0.70
0.59
0.91
1.09
Asset Turnover Ratio
1.71
1.48
1.13
1.51
1.61
---
126.40
17.21
98.54
47.27
80.12
60.96
89.42
36.15
151.96
174.21
209.89
156.05
115.39
Net Operating Profit Per Share (Rs)

Free Reserves Per Share (Rs)
Interest Cover
Total Debt to Owners Fund
Average Raw Material Holding

Average Finished Goods Held
Number of Days In Working Capital
Profit & Loss Account Ratios

Material Cost Composition
Imported Composition of Raw Materials
Consumed
42.98
38.91
43.59
47.25
44.42
--
--
--
--
--
Selling Distribution Cost Composition
--
2.40
2.11
1.67
2.33
Expenses as Composition of Total Sales

Cash Flow Indicator Ratios
--
--
--
--
--
Dividend Payout Ratio Net Profit

Dividend Payout Ratio Cash Profit
37.60
33.68
35.89
31.92
27.16
23.48
10.92
9.73
8.69
7.73
Earning Retention Ratio

Cash Earning Retention Ratio
62.40
66.32
64.03
68.02
72.38
76.18
89.96
90.98
91.13
92.13
0.09
0.05
0.08
0.10
0.22
AdjustedCash Flow Times
Key Financial Ratios of Cipla
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
Face Value
Dividend Per Share
2.00
2.00
19.90
86.90
91.92
94.44
2.00
2.80
15.96
78.70
80.25
94.44
2.00
2.00
17.20
69.82
71.54
94.44
2.00
2.00
16.02
67.34
53.86
97.55
2.00
2.00
10.96
54.08
46.20
97.55

22.89
18.94
19.15
19.37
19.37
15.92
15.92
18.74
14.90
14.67
93.92
94.04
18.77
20.27
16.41
16.65
18.25
18.25
14.98
14.98
16.22
14.54
14.25
82.25
82.36
17.29
24.63
21.32
21.68
21.11
21.11
18.97
18.97
22.16
18.31
17.57
73.55
73.66
22.16
23.78
20.52
20.88
21.75
21.75
14.58
14.58
22.39
17.89
23.17
55.86
55.97
26.79
20.27
16.90
17.16
17.85
17.85
16.43
16.43
18.17
18.72
16.85
48.20
48.32
18.24
3.12
1.89
---
1.94
1.56
0.07
--
2.17
1.57
---
1.81
1.93
0.22
0.02
2.62
1.88
0.15
0.15
Current Ratio
Quick Ratio
Debt Equity Ratio
Interest Cover
116.74
0.00
138.27
115.18
222.40
0.07
126.22
110.41
57.08
0.00
52.13
45.05
35.92
0.22
25.56
18.78
67.27
0.15
50.81
47.10

3.88
4.63
3.73
4.14
4.18
3.31
3.79
3.24
3.83
3.47
3.88
3.73
4.18
3.79
3.83
1.62
1.61
1.94
1.94
1.91
0.92
0.90
0.95
0.99
0.97
1.62
1.61
1.94
1.94
1.91
177.56
110.90
113.47
203.30
181.28
39.66
43.20
41.38
41.54
37.36
160.15
191.58
190.01
196.07
201.02

Consumed
41.61
48.83
47.94
48.01
51.44
38.68
40.63
43.85
42.63
44.03
6.66
6.10
5.82
7.17
6.77

53.43
54.08
54.54
56.55
53.65
16.60
27.23
17.31
23.41
25.92
13.47
21.99
15.01
19.58
21.85
83.14
72.22
81.97
81.93
71.20

86.36
0.01
77.65
0.38
84.44
0.00
84.30
0.81
76.14
0.76
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
Earnings Per Share
14.00
11.96
13.47
9.99
9.02
Book Value
93.92
82.25
73.55
55.86
48.20
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
5.00
13.75
109.80
5.00
11.25
72.05
5.00
11.25
64.47
5.00
6.25
44.99
5.00
3.75
34.65

Key Financial Ratios of Dr Reddys

Laboratories

Face Value
Dividend Per Share
394.33
306.55
260.33
237.40
198.84
380.00
346.32
341.13
304.97
278.46
65.87
66.03
66.19
66.34
66.43
27.84
23.50
24.76
18.95
17.42
23.11
18.31
18.92
13.28
12.01
23.34
18.72
19.70
14.11
12.58
22.38
21.99
22.17
19.10
17.59
22.38
21.99
22.17
19.10
17.59
13.51
16.84
18.48
13.20
13.57
13.51
16.84
18.48
13.20
13.57
19.22
14.20
15.87
13.46
10.55
13.58
14.84
14.30
10.66
9.87

17.42
14.81
13.07
11.37
9.00
396.19
355.69
350.30
312.17
286.12
396.19
355.69
350.30
312.17
286.12
21.93
16.22
17.36
15.08
11.54
Current Ratio
1.70
1.66
1.49
1.85
1.82
Quick Ratio
1.84
1.91
1.45
2.13
1.94
Debt Equity Ratio
0.23
0.24
0.10
0.12
0.10
0.08
0.09
--
--
--
25.22
220.90
250.76
53.32
85.79


Interest Cover
0.23
0.24
0.10
0.12
0.10
27.86
134.85
79.36
36.78
50.33
19.12
118.99
68.99
29.26
45.79
5.54
5.36
5.39
6.09
5.90
3.60
3.67
3.54
3.45
3.42
5.54
5.36
5.39
6.09
5.90
1.94
1.75
1.86
1.91
1.97
0.82
0.70
0.69
0.69
0.64
1.94
1.75
1.86
1.91
1.97
109.87
134.48
104.48
108.84
104.05
19.27
22.23
18.28
15.37
14.65
174.40
190.22
144.48
217.13
211.04
31.74
33.71
36.38
38.35
40.29

Consumed
27.05
42.76
30.36
38.75
26.37
9.34
9.19
10.09
11.21
11.22
73.83
72.23
71.92
78.09
70.77
29.69
34.20
26.19
21.94
15.52
21.60
26.16
20.37
15.90
11.21
76.86
65.74
71.35
79.43
82.97



Earnings Per Share

Book Value
82.08
73.81
78.17
84.84
88.02
1.01
1.24
0.55
0.79
0.75
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
53.81
52.78
50.11
33.29
28.26
396.19
355.69
350.30
312.17
286.12
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
5.00
5.00
16.68
77.77
95.15
93.47
5.00
4.50
15.86
66.32
88.18
93.47
5.00
3.50
13.16
56.42
70.17
93.47
5.00
3.00
10.46
45.21
61.63
93.47
5.00
5.00
17.63
83.40
124.09
86.94
21.44
15.00
15.39
20.30
20.30
16.00
16.00
12.52
12.19
10.98
104.78
104.82
13.02
23.91
14.21
17.07
32.88
32.88
28.82
28.82
23.34
23.60
22.26
97.29
97.34
24.45
23.32
14.92
16.26
27.18
27.18
20.20
20.20
16.18
15.86
16.25
78.27
78.31
17.42
23.14
13.66
14.92
28.09
28.09
11.31
11.31
14.21
8.13
14.79
68.70
68.74
15.21
21.13
11.51
12.86
27.89
27.89
46.70
46.70
13.90
32.76
14.37
132.72
132.82
14.80
2.03
1.76
0.07
0.03
2.06
2.21
0.09
0.04
1.53
1.69
0.12
0.04
1.44
1.71
0.12
0.05
1.16
1.30
0.11
0.04
165.18
488.04
241.91
55.30
92.93
Key Financial Ratios of Biocon

Face Value
Dividend Per Share
Current Ratio
Quick Ratio
Debt Equity Ratio
Interest Cover
0.07
0.09
0.12
0.12
0.11
220.47
245.71
182.87
59.32
88.45
206.59
232.29
165.78
38.69
163.95
4.90
5.10
4.82
4.91
5.19
3.60
3.31
3.25
3.38
3.33
4.90
5.10
4.82
4.91
5.19
1.31
1.21
1.13
0.95
0.98
0.70
0.63
0.65
0.60
0.58
1.31
1.21
1.13
0.95
0.98
54.25
48.61
54.39
64.19
71.97

20.14
11.38
7.87
7.23
6.38
182.37
229.80
192.28
175.29
108.23
52.65
52.37
53.94
48.97
49.24

Consumed
61.16
68.06
63.15
64.34
65.34
5.33
4.25
3.56
3.83
3.76
43.54
52.28
44.81
52.17
62.66
45.47
21.57
31.17
62.78
13.45
33.24
18.01
23.59
37.72
11.60
49.53
77.14
69.59
65.47
69.35
64.16
81.10
76.84
74.71
77.49
0.45
0.32
0.57
0.59
0.55
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
12.78
22.96
12.42
5.59
43.49
104.78
97.29
78.27
68.70
132.72


Earnings Per Share

Book Value
Key Financial Ratios of Aurobindo Pharma
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
1.00
1.00
1.00
2.00
5.00
5.00
5.00
4.50
5.00
3.25

Face Value
Dividend Per Share

21.36
33.24
135.89
96.13
59.06
147.18
141.88
583.55
519.83
415.63
84.02
86.64
335.26
237.31
218.67
59.60
59.60
62.28
64.55
64.55
14.51
23.42
23.28
18.49
14.20
11.13
20.34
20.25
15.37
10.37
11.17
20.40
20.35
15.54
10.87
15.31
17.24
16.09
15.24
13.30
15.31
17.24
16.09
15.24
13.30
-0.99
14.33
16.09
4.54
12.41
-0.99
14.33
16.09
4.54
12.41
10.04
17.48
17.54
13.53
11.76
-1.70
23.10
27.46
9.73
23.82
20.69
22.93
22.47
26.38
19.42
85.64
88.27
343.51
245.67
227.02
85.64
88.27
343.51
245.67
227.02
14.90
23.31
24.57
18.94
14.80
Current Ratio
0.76
1.21
1.05
1.12
1.35
Quick Ratio
1.60
2.22
2.28
2.99
2.97
Debt Equity Ratio
0.98
0.90
1.02
1.60
1.44
0.33
0.43
0.44
0.86
0.94
Interest Cover
6.79
22.90
12.47
6.44
6.64
0.98
0.90
1.02
1.60
1.44
6.86
17.81
12.34
6.74
7.20
2.08
14.07
10.93
3.60
7.19
4.09
3.71
3.89
4.36
3.94
2.95
3.14
2.88
2.93
3.14
4.09
3.71
3.89
4.36
3.94
1.82
2.12
2.14
2.22
1.98
0.87
0.85
0.84
0.81
0.75
1.82
2.12
2.14
2.22
1.98
92.66
91.53
81.12
81.40
86.27
7.56
17.66
15.49
9.02
6.13
177.77
214.53
214.21
257.48
279.42
60.65
60.21
61.80
62.64
66.73
60.81
65.35
68.69
76.47
72.98
3.28
2.83
3.75
4.55
2.95
69.50
70.99
68.02
66.08
64.34
--
11.51
6.16
22.02
7.06

Consumed
33.71
9.50
5.21
13.42
5.62
--
88.40
92.47
91.88
91.34
94.87
90.43
93.84
93.43
93.41
3.71
3.24
3.70
4.91
5.63
Mar
'12
Mar '11
Mar '10
Mar '09
Mar '08
Earnings Per Share
-1.46
20.40
94.34
23.91
54.08
Book Value
85.64
88.27
343.51
245.67
227.02

Divis Laboratories: Consolidated Balance Sheet of - in Rs. Cr.

Enviado por

Dados do documento

Título original

Direitos autorais

Formatos disponíveis

Compartilhar este documento

Compartilhar ou incorporar documento

Opções de compartilhamento

Você considera este documento útil?

Este conteúdo é inapropriado?

Direitos autorais:

Formatos disponíveis

Divis Laboratories: Consolidated Balance Sheet of - in Rs. Cr.

Enviado por

Direitos autorais:

Formatos disponíveis

Consolidated Balance Sheet of Divis

------------------- in Rs. Cr. -------------------

Total Share Capital

Equity Share Capital

Share Application Money

Preference Share Capital

Init. Contribution Settler

Preference Share Application Money

Employee Stock Opiton

Policy Holders Funds

Group Share in Joint Venture

Less: Accum. Depreciation

Capital Work in Progress

Total Current Assets

Loans and Advances

Total CL & Provisions

Net Current Assets

Cash and Bank Balance

Group Share in Joint Venture

Book Value (Rs)

Balance Sheet of Cipla

------------------- in Rs. Cr. ------------------Mar '12

Total Share Capital

Equity Share Capital

Share Application Money

Preference Share Capital

Less: Accum. Depreciation

Capital Work in Progress

Cash and Bank Balance

Total Current Assets

Loans and Advances

Total CL & Provisions

Net Current Assets

------------------- in Rs. Cr. -------------------

Total Share Capital

Equity Share Capital

Preference Share Capital

Less: Accum. Depreciation

Capital Work in Progress

Total Current Assets

Loans and Advances

Total CA, Loans & Advances

Total CL & Provisions

Book Value (Rs)

Balance Sheet of Biocon

------------------- in Rs. Cr. ------------------Mar '12

Total Share Capital

Equity Share Capital

Share Application Money

Less: Accum. Depreciation

Capital Work in Progress

Total Current Assets

Loans and Advances

Total CL & Provisions

Book Value (Rs)

Total CA, Loans & Advances

------------------- in Rs. Cr. ------------------Mar '12

Total Share Capital

Equity Share Capital

Share Application Money

Less: Accum. Depreciation

Capital Work in Progress

Cash and Bank Balance